Abstract
SAFE-DCB is a prospective, multi-center registry designed to assess patient outcomes and safety following the use of the Lutonix® paclitaxel-coated angioplasty balloon (DCB) for the treatment of de-novo or restenotic lesions (non-stent) in the superficial femoral (SFA) or popliteal arteries (PA) in
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
